Jefferies Financial Group Inc. purchased a new position in Aspen Aerogels, Inc. (NYSE:ASPN – Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 126,303 shares of the construction company’s stock, valued at approximately $801,000. Jefferies Financial Group Inc. owned about 0.15% of Aspen Aerogels at the end of the most recent reporting period.
Other large investors also recently modified their holdings of the company. BlackRock Inc. purchased a new stake in Aspen Aerogels during the second quarter valued at $33,457,000. Oaktop Capital Management II L.P. purchased a new position in Aspen Aerogels in the second quarter worth about $32,769,000. Vanguard Group Inc. grew its stake in shares of Aspen Aerogels by 0.5% during the 3rd quarter. Vanguard Group Inc. now owns 4,510,370 shares of the construction company’s stock valued at $31,392,000 after purchasing an additional 22,686 shares during the period. Needham Investment Management LLC grew its stake in shares of Aspen Aerogels by 26.5% during the 4th quarter. Needham Investment Management LLC now owns 4,351,700 shares of the construction company’s stock valued at $12,315,000 after purchasing an additional 912,000 shares during the period. Finally, Invesco Ltd. increased its position in shares of Aspen Aerogels by 237.9% during the 4th quarter. Invesco Ltd. now owns 4,129,934 shares of the construction company’s stock valued at $11,688,000 after purchasing an additional 2,907,558 shares during the last quarter. Institutional investors own 97.64% of the company’s stock.
Aspen Aerogels Price Performance
NYSE ASPN opened at $4.93 on Monday. The stock’s 50-day moving average price is $5.40 and its 200-day moving average price is $4.65. The company has a quick ratio of 2.24, a current ratio of 2.52 and a debt-to-equity ratio of 0.36. Aspen Aerogels, Inc. has a 52 week low of $2.30 and a 52 week high of $9.35. The company has a market capitalization of $409.14 million, a P/E ratio of -3.22 and a beta of 2.99.
Wall Street Analyst Weigh In
Several brokerages have recently weighed in on ASPN. Wall Street Zen cut shares of Aspen Aerogels from a “hold” rating to a “sell” rating in a research note on Saturday, August 15th. Roth Capital reaffirmed a “buy” rating and set a $7.75 target price on shares of Aspen Aerogels in a report on Friday, August 7th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Aspen Aerogels in a report on Wednesday, June 24th. Barclays lifted their price target on shares of Aspen Aerogels from $4.00 to $5.00 and gave the stock an “underweight” rating in a research note on Tuesday, August 11th. Finally, B. Riley Financial reissued a “buy” rating on shares of Aspen Aerogels in a research report on Friday, August 7th. Four equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, Aspen Aerogels presently has a consensus rating of “Hold” and a consensus target price of $5.94.
Get Our Latest Stock Report on ASPN
Aspen Aerogels Profile
Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.
The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.
Further Reading
- Five stocks we like better than Aspen Aerogels
- Strike a Balance Between Growth and Stability With These 3 Names Ready to Rally
- Rubrik’s AI Security Bet Could Power the Next Leg Higher
- Apple’s Foldable iPhone Could Be a Catalyst, But Not a Cure-All
- Snowflake Is Up Nearly 50% in 2026—What Are Short Sellers Betting Against?
Want to see what other hedge funds are holding ASPN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aspen Aerogels, Inc. (NYSE:ASPN – Free Report).
Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.
